View : 64 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author이수진-
dc.date.accessioned2021-06-18T16:33:55Z-
dc.date.available2021-06-18T16:33:55Z-
dc.date.issued2019-
dc.identifier.issn1524-9557-
dc.identifier.issn1537-4513-
dc.identifier.otherOAK-25391-
dc.identifier.uriD:/dspace/dspace55/handle/2015.oak/257759-
dc.description.abstractWe performed a prospective immunohistochemical analysis of lymphocyte activation gene 3 (LAG3) for 430 consecutive patients with advanced gastrointestinal, genitourinary, or rare cancers between June 2012 and March 2016. Most patients (428/430, 99.5%) were evaluable for LAG3 expression by immunohistochemistry. In total, 18.5% (79/428) of the evaluated cancers expressed LAG3, including pancreatic cancer (33.3%, 2/6), gastric cancer (24.7%, 21/85), colorectal cancer (23.6%, 48/203), melanoma (12.5%, 1/8), genitourinary cancer (9.5%, 4/46), biliary tract cancer (6.3%, 1/16), and sarcoma (5.4%, 2/37), but not miscellaneous (0.0%, 0/14) or hepatocellular (0.0%, 0/15) cancer. Among 149 metastatic colorectal cancer patients, there was no statistically significant difference in sex, age, primary tumor site, pathologic differentiation, KRAS and NRAS status, BRAF status, and microsatellite instability according to LAG3 status (expressed vs. nonexpressed). Among 53 metastatic gastric cancer patients, LAG3 was only significantly associated with Epstein Barr virus status (P=0.042). Our results add to the emerging literature on LAG3 expression in various cancer types and support the need for extended clinical exploration of this target for immunotherapy.-
dc.languageEnglish-
dc.publisherLIPPINCOTT WILLIAMS &amp-
dc.publisherWILKINS-
dc.subjectLAG3-
dc.subjectimmunohistochemistry-
dc.subjectbiomarker-
dc.subjectsolid cancer-
dc.subjectimmunotherapy-
dc.titleLAG3 in Solid Tumors as a Potential Novel Immunotherapy Target-
dc.typeArticle-
dc.relation.issue8-
dc.relation.volume42-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.startpage279-
dc.relation.lastpage283-
dc.relation.journaltitleJOURNAL OF IMMUNOTHERAPY-
dc.identifier.doi10.1097/CJI.0000000000000283-
dc.identifier.wosidWOS:000485935900001-
dc.identifier.scopusid2-s2.0-85071787714-
dc.author.googleLee, Su Jin-
dc.author.googleByeon, Sun-Ju-
dc.author.googleLee, Jeeyun-
dc.author.googlePark, Se Hoon-
dc.author.googlePark, Joon Oh-
dc.author.googlePark, Young Suk-
dc.author.googleKang, Won Ki-
dc.author.googleLim, Ho Yeong-
dc.author.googleKim, Kyoung-Mee-
dc.author.googleKim, Seung Tae-
dc.contributor.scopusid이수진(57201133000)-
dc.date.modifydate20210708162936-
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE